Cytotoxic Activity of Some Spirooxindole-4H-pyran Derivatives

Main Article Content

Zeinab Faghih
Zahra Faghih
Masoomeh Divar
Soghra Khabnadideh

Abstract

Aims: Isatin is a honored scaffold and one of the most favorable class of heterocyclic systems that possesses many interesting biological activities and well-tolerated in humans. Here a series of fifteen spirooxindole-4H-pyran derivatives containing both isatin and pyran moieties (ICa-ICo) will be examine for their anti-cancer activity.

Study Design: Cytotoxic evaluation of some spirooxindole-4H-pyran derivatives in two cancerous cell lines. 

Place and Duration of Study: Pharmaceutical Science Research Center and Shiraz Institute for Cancer Research, Medical School in Shiraz University of Medical Sciences, Shiraz, Iran, between June 2018 and July 2019.

Methodology: MTT assay was used to evaluate the cytotoxic activities of these compounds. The anticancer properties of the tested compounds were determined using A549 and MCF-7 cell lines.

Results: Among the tested compounds ICc, ICdand ICfshowed the best cytotoxic activities  against both cancerous cell lines. Compounds IChand ICj showed desirable cytotoxic activities against A549 cell line. Compound ICb showed desirable cytotoxic activities against MCF-7 cell line.

Conclusion: We conclude that the isatin-linked pyran analog can serve as a prototype molecule for further development of a new class of anticancer agents.

Keywords:
Spirooxindole-4H-pyran, cytotoxic activity, MTT

Article Details

How to Cite
Faghih, Z., Faghih, Z., Divar, M., & Khabnadideh, S. (2019). Cytotoxic Activity of Some Spirooxindole-4H-pyran Derivatives. Journal of Pharmaceutical Research International, 31(6), 1-6. https://doi.org/10.9734/jpri/2019/v31i630364
Section
Original Research Article

References

Eldehna WM, Altoukhy A, Mahrous H, Abdel-Aziz HA. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents. European Journal of Medicinal Chemistry. 2015;90:684-94.

Viegas-Junior C, Danuello A, da Silva Bolzani V, Barreiro EJ, Fraga CAM. Molecular hybridization: A useful tool in the design of new drug prototypes. Current Medicinal Chemistry. 2007;14(17):1829- 52.

Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. The global burden of cancer 2013. JAMA Oncology. 2015;1(4):505-27.

Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of cancer chemotherapy. Nature reviews immunology. 2008;8(1):59.

Gottesman MM. Mechanisms of cancer drug resistance. Annual Review of Medicine. 2002;53(1):615-27.

Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: An evolving paradigm. Nature Reviews Cancer. 2013;13(10):714.

Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: A brief review. Advanced pharmaceutical bulletin. 2017;7(3):339.

Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, et al. Drug resistance in cancer: An overview. Cancers. 2014;6(3):1769-92.

Bahar E, Kim JY, Yoon H. Chemotherapy Resistance Explained through Endo-plasmic Reticulum Stress-Dependent Signaling. Cancers. 2019;11(3):338.

Solomon VR, Hu C, Lee H. Hybrid pharmacophore design and synthesis of isatin–benzothiazole analogs for their anti-breast cancer activity. Bioorganic & Medicinal Chemistry. 2009;17(21):7585-92.

K Ramshid P, Jagadeeshan S, Krishnan A, Mathew M, Asha Nair S, Radhakrishna Pillai M. Synthesis and in vitro evaluation of some isatin-thiazolidinone hybrid analogues as anti-proliferative agents. Medicinal Chemistry. 2010;6(5):306- 12.

Sridhar S, Pandeya S, De EC. Synthesis and anti-HIV activity of some isatin derivatives. Bollettino Chimico Farmaceutico. 2001;140(5):302-5.

Kakkar R. Isatin and its derivatives: a survey of recent syntheses, reactions, and applications. MedChemComm. 2019.

Xu Z, Zhang S, Gao C, Fan J, Zhao F, Lv Z-S, et al. Isatin hybrids and their anti-tuberculosis activity. Chinese Chemical Letters. 2017;28(2):159-67.

Kumar D, Sharma P, Singh H, Nepali K, Gupta GK, Jain SK, et al. The value of pyrans as anticancer scaffolds in medicinal chemistry. RSC Advances. 2017;7(59): 36977-99.

Kumar KA, Renuka N, Kumar GV, Lokeshwari D. Pyrans: Heterocycles of chemical and biological interest. Journal of Chemical and Pharmaceutical Research. 2015;7(11):693-700.

Wang C. Synthesis and biological evaluation of tetrahydrobenzo [b] pyran derivatives as potential anti-ovarian cancer agents. Biomedical Research-India. 2016; 27:S322-S5.

Yu B, Yu D-Q, Liu H-M. Spirooxindoles: Promising scaffolds for anticancer agents. European Journal of Medicinal Chemistry. 2015;97:673-98.

Shi X-J, Yu B, Wang J-W, Qi P-P, Tang K, Huang X, et al. Structurally novel steroidal spirooxindole by241 potently inhibits tumor growth mainly through ROS-mediated mechanisms. Scientific reports. 2016;6: 31607.

Mohammadi Ziarani G, Hosseini Mohtasham N, Lashgari N, Badiei A, Amanlou M, Bazl R. Convenient one- pot synthesis of spirooxindole-4H-pyrans in the presence of SBA-Pr-NH2 and evaluation of their urease inhibitory activities. Journal of Nanostructures. 2012; 2(4):489-500.

Decker M. Hybrid molecules incorporating natural products: Applications in cancer therapy, neurodegenerative disorders and beyond. Current Medicinal Chemistry. 2011;18(10):1464-75.

Divar M, Khabnadideh S, Sabet R, Zomorodian K, Ershadi N, Hassanpour F. An Efficient Method for Synthesis of Some Novel Spiro [indoline-thiazolidine] dione Derivatives. Chemical Methodologies. 2019;3(2):237-50,145-275.

Faghih Z, Neshat A, Wojtczak A, Faghih Z, Mohammadi Z, Varestan S. Palladium (II) complexes based on Schiff base ligands derived from ortho-vanillin; synthesis, characterization and cytotoxic studies. Inorganica Chimica Acta. 2018;471:404-12.

Fereidoonnezhad M, Shahsavari HR, Lotfi E, Babaghasabha M, Fakhri M, Faghih Z, et al. (Benzyl isocyanide) gold (I) pyrimidine‐2‐thiolate complex: Synthesis and biological activity. Applied Organometallic Chemistry. 2018;32(3): e4200.

Sylvester PW. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Drug design and discovery: Springer. 2011:157-68.

Singh H, Singh JV, Gupta MK, Saxena AK, Sharma S, Nepali K, et al. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Bioorganic & Medicinal Chemistry Letters. 2017;27(17): 3974-9.

Thota S, Nadipelly K, Shenkesi A, Yerra R. Design, synthesis, characterization, antioxidant and in vitro cytotoxic activities of novel coumarin thiazole derivatives. Medicinal Chemistry Research. 2015; 24(3):1162-9.